CIK 0001652130
- Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364785571
- Phone
- +1 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- 4 Grant or award EVP, Chief Scientific Officer acquired 37,966 shares (grant or award)
- 4 Open-market sale EVP, General Counsel sold 2,297 shares at $32.99 ($75,778)
- 4 Grant or award EVP, Chief Business Officer acquired 29,393 shares (grant or award)
- 4 Open-market sale EVP, Chief Technical Officer sold 605 shares at $32.99 ($19,959)
- 4 Grant or award President and CEO acquired 113,586 shares (grant or award)
- 4 Grant or award EVP, Chief Medical Officer acquired 38,701 shares (grant or award)
- 4 Grant or award EVP, Chief Financial Officer acquired 28,628 shares (grant or award)
- 4 Planned sale EVP, Chief Scientific Officer sold 2,275 shares at an average $28.87 ($65,682)
- 4 Open-market sale President and CEO sold 19,223 shares at $29.46 ($566,310)
- 4 Open-market sale EVP, Chief Medical Officer sold 5,843 shares at $29.46 ($172,135)
- 4 Open-market sale EVP, Chief Scientific Officer sold 5,532 shares at $29.46 ($162,973)
- 4 Open-market sale EVP, Chief Financial Officer sold 5,365 shares at $29.46 ($158,053)
- 4 Open-market sale EVP, Chief Business Officer sold 3,877 shares at $29.46 ($114,216)
- 4 Open-market sale EVP, General Counsel sold 3,805 shares at $29.46 ($112,095)
- 4 Open-market sale EVP, Chief Technical Officer sold 4,608 shares at an average $29.50 ($135,954)
- 4 Exercise or conversion EVP, Chief Scientific Officer acquired 3,500 shares (option exercise)
- 4 Exercise or conversion EVP, Chief Medical Officer acquired 3,187 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 7,848 shares (option exercise)
- 4 Exercise or conversion EVP, Chief Financial Officer acquired 3,062 shares (option exercise)
- 4 Planned sale Director sold 265 shares at $23.90 ($6,334)
Page 5 of 18 · 353 filings